It seems that anything is possible under existing law and PBAC guidelines so patients still waiting for positive outcomes should certainly recalibrate their expectations. …
Why bother with the HTA review if the system can already do almost anything it wants?
July 18, 2022 Latest NewsBioPharmaComment
Latest Video
New Stories
-
This unique historical oddity says all we need to know about the institution
May 26, 2026 - - Latest News -
New Zealand's Pharmac consulting on new vaccine brands and wider flu access for young children
May 26, 2026 - - Latest News -
New national survey reveals muscle health screening gap in Australian general practice
May 26, 2026 - - Latest News -
Mayne Pharma awarded legal costs as business expansion gains momentum
May 25, 2026 - - Latest News -
The risk to patients of this institution getting too close to the sun
May 25, 2026 - - Latest News -
Pharmacy Guild urges immediate funding for pharmacy to vaccinate in response to outbreak
May 24, 2026 - - Latest News -
AusBiotech launches survey in response to Budget’s 'blind spot' on R&D impact
May 24, 2026 - - Australian Biotech